Literature DB >> 31020439

The effect of endometriosis on the antimüllerian hormone level in the infertile population.

Phillip A Romanski1, Paula C Brady2, Leslie V Farland3, Ann M Thomas2, Mark D Hornstein2.   

Abstract

PURPOSE: To determine whether the presence of endometriosis in infertile women without prior ovarian surgery influences markers of ovarian reserve, AMH and FSH.
METHODS: A retrospective cohort study included three groups of women who presented for IVF treatment at our tertiary care center from 04/27/2015 to 05/31/2017: women with endometriosis and prior ovarian surgery (EnSx), women with endometriosis without prior ovarian surgery (En), and women with a primary diagnosis of male factor infertility (MF; reference group).
RESULTS: There were 671 patients that met inclusion criteria (78 EnSx, 60 En, and 533 MF). Compared to the MF group (3.6 ± 3.0), a lower mean AMH level (ng/mL) was observed in the EnSx group (2.5 ± 2.5; aβ - 1.21; 95% CI [- 1.79, -0.62]) and in the En group (2.5 ± 2.2; aβ - 1.11; 95% CI [- 1.68, - 0.54]). Both endometriosis groups had a statistically significantly higher proportion of patients with an AMH < 1 (EnSx, 24.4%; OR, 2.39 [95% CI, 1.31, 4.36]; En, 28.3%; OR, 2.67 [95% CI, 1.41, 5.08]) compared to the MF group (13.9%). The mean baseline FSH level (lU/L) was statistically significantly higher in both endometriosis groups (EnSx, 8.6 ± 4.3; β, 1.37 [95% CI, 0.39, 2.34]; En, 8.4 ± 3.7; β, 0.96 [95% CI, 0.04, 1.87]) compared to the MF group (7.3 ± 2.2).
CONCLUSIONS: Among infertility patients with endometriosis, with and without a history of ovarian surgery, ovarian reserve markers were worse (lower AMH and higher FSH) and a higher proportion had decreased ovarian reserve as measured by AMH compared to women with MF.

Entities:  

Keywords:  AMH; Antimüllerian hormone; Endometriosis; Infertility; Ovarian reserve

Mesh:

Substances:

Year:  2019        PMID: 31020439      PMCID: PMC6603105          DOI: 10.1007/s10815-019-01450-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  28 in total

1.  Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women.

Authors:  Bjarne K Jacobsen; Ivar Heuch; Gunnar Kvåle
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

Review 2.  Premature ovarian failure and ovarian autoimmunity.

Authors:  A Hoek; J Schoemaker; H A Drexhage
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

3.  Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.

Authors:  H W R Li; B P C Wong; W K Ip; W S B Yeung; P C Ho; E H Y Ng
Journal:  Hum Reprod       Date:  2016-10-04       Impact factor: 6.918

Review 4.  Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications.

Authors:  Edgardo Somigliana; Nicola Berlanda; Laura Benaglia; Paola Viganò; Paolo Vercellini; Luigi Fedele
Journal:  Fertil Steril       Date:  2012-09-10       Impact factor: 7.329

5.  Defining ovarian reserve to better understand ovarian aging.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-02-07       Impact factor: 5.211

6.  Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

Authors:  Ellen W Freeman; Clarisa R Gracia; Mary D Sammel; Hui Lin; Lony Chong-Leong Lim; Jerome F Strauss
Journal:  Fertil Steril       Date:  2006-11-15       Impact factor: 7.329

7.  Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; David W Boorman; Clarisa R Gracia
Journal:  Fertil Steril       Date:  2012-08-24       Impact factor: 7.329

8.  Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.

Authors:  David B Seifer; Elizabeth T Golub; Geralyn Lambert-Messerlian; Lorie Benning; Kathryn Anastos; D Heather Watts; Mardge H Cohen; Roksana Karim; Mary A Young; Howard Minkoff; Ruth M Greenblatt
Journal:  Fertil Steril       Date:  2008-10-18       Impact factor: 7.329

9.  The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years.

Authors:  Beth J Plante; Glinda S Cooper; Donna D Baird; Anne Z Steiner
Journal:  Menopause       Date:  2010 May-Jun       Impact factor: 2.953

Review 10.  Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

Authors:  A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe
Journal:  Hum Reprod Update       Date:  2009-09-30       Impact factor: 15.610

View more
  8 in total

1.  Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study.

Authors:  Mari Uehara; Osamu Wada-Hiraike; Mana Hirano; Kaori Koga; Noriko Yoshimura; Sakae Tanaka; Yutaka Osuga
Journal:  BMC Womens Health       Date:  2022-04-27       Impact factor: 2.742

Review 2.  Hormonal treatments for endometriosis: The endocrine background.

Authors:  Silvia Vannuccini; Sara Clemenza; Margherita Rossi; Felice Petraglia
Journal:  Rev Endocr Metab Disord       Date:  2021-08-17       Impact factor: 9.306

Review 3.  Impact of Surgical Management of Endometrioma on AMH Levels and Pregnancy Rates: A Review of Recent Literature.

Authors:  Ana Sofia Pais; Clara Flagothier; Linda Tebache; Teresa Almeida Santos; Michelle Nisolle
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

4.  Correlation of Serum Anti-Mullerian Hormone (AMH) Level on Ovarian Volume in Women with Endometrioma.

Authors:  Dodi Suardi; Wiryawan Permadi; Tono Djuwantono; Yudi Mulyana Hidayat; Hartanto Bayuaji; Gusti Putu Edo Gautama
Journal:  Int J Gen Med       Date:  2021-01-06

5.  Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.

Authors:  Yaoqiu Wu; Rong Yang; Jie Lan; Haiyan Lin; Xuedan Jiao; Qingxue Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-22       Impact factor: 5.555

6.  TGFß Gene Members and Their Regulatory Factors in Granulosa Compared to Cumulus Cells in PCOS: A Case-Control Study.

Authors:  Faezeh Alvandian; Elham Hosseini; Zohre Hashemian; Mona Khosravifar; Bahar Movaghar; Maryam Shahhosein; Marzieh Shiva; Parvaneh Afsharian
Journal:  Cell J       Date:  2022-07-27       Impact factor: 3.128

Review 7.  Endometriosis and polycystic ovary syndrome are diametric disorders.

Authors:  Natalie L Dinsdale; Bernard J Crespi
Journal:  Evol Appl       Date:  2021-05-14       Impact factor: 4.929

8.  Association Between Laparoscopically Confirmed Endometriosis and Risk of Early Natural Menopause.

Authors:  Madhavi Thombre Kulkarni; Amy Shafrir; Leslie V Farland; Kathryn L Terry; Brian W Whitcomb; A Heather Eliassen; Elizabeth R Bertone-Johnson; Stacey A Missmer
Journal:  JAMA Netw Open       Date:  2022-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.